相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis
Niveditha Muralidharan et al.
CLINICAL RHEUMATOLOGY (2016)
Impact of SLCO1B1 521T > C Variant on Leucovorin Rescue and Risk of Relapse in Childhood Acute Lymphoblastic Leukemia Treated With High-Dose Methotrexate
Hua-Nian Zhang et al.
PEDIATRIC BLOOD & CANCER (2014)
Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma
Katja Goricar et al.
PHARMACOGENETICS AND GENOMICS (2014)
SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients
Aurea Lima et al.
PHARMACOGENOMICS (2014)
Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update
Hong Zhu et al.
PHARMACOGENOMICS (2014)
SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients
Aurea Lima et al.
TOXICOLOGICAL SCIENCES (2014)
Prediction of Methotrexate Clinical Response in Portuguese Rheumatoid Arthritis Patients: Implication of MTHFR rs1801133 and ATIC rs4673993 Polymorphisms
Aurea Lima et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Association of Functional Polymorphism rs2231142 ( Q141K) in the ABCG2 Gene With Serum Uric Acid and Gout in 4 US Populations The PAGE Study
Lili Zhang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia
Susanne Radtke et al.
BLOOD (2013)
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?
Vasco Crispim Romao et al.
BMC MEDICINE (2013)
A Population Pharmacokinetic Model for Low-Dose Methotrexate and its Polyglutamated Metabolites in Red Blood Cells
Julia Korell et al.
CLINICAL PHARMACOKINETICS (2013)
Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics
Aurea Lima et al.
PHARMACOGENOMICS (2013)
Methotrexate pharmacogenetics in rheumatoid arthritis: a status report
Fardina Malik et al.
PHARMACOGENOMICS (2013)
Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression
T. D. Nguyen et al.
PHARMACOGENOMICS JOURNAL (2013)
Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy
N. Simon et al.
PHARMACOGENOMICS JOURNAL (2013)
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
S. A. Owen et al.
PHARMACOGENOMICS JOURNAL (2013)
Genetic Polymorphisms in Metabolic and Cellular Transport Pathway of Methotrexate Impact Clinical Outcome of Methotrexate Monotherapy in Japanese Patients with Rheumatoid Arthritis
Tomomi Kato et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Laura B. Ramsey et al.
GENOME RESEARCH (2012)
ABCB1 and ABCC3 Gene Polymorphisms Are Associated with First-year Response to Methotrexate in Juvenile Idiopathic Arthritis
Maurits C. F. J. de Rotte et al.
JOURNAL OF RHEUMATOLOGY (2012)
Pharmacogenetic Polymorphisms Contributing to Toxicity Induced by Methotrexate in the Southern Spanish Population with Rheumatoid Arthritis
Jose Cristian Plaza-Plaza et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients
Petra Bohanec Grabar et al.
PHARMACOGENOMICS (2012)
Markers of Treatment Response toMethotrexate in Rheumatoid Arthritis: Where Do We Stand?
Karina I. Halilova et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2012)
Interindividual Variability in Hepatic Expression of the Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2): Quantification by Liquid Chromatography/Tandem Mass Spectrometry
Anand K. Deo et al.
DRUG METABOLISM AND DISPOSITION (2012)
Subcellular localization and distribution of the reduced folate carrier in normal rat tissues
M. Hinken et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2011)
PharmGKB summary: methotrexate pathway
Torben S. Mikkelsen et al.
PHARMACOGENETICS AND GENOMICS (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
Maurizio Benucci et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
MRP1 Polymorphisms Associated With Citalopram Response in Patients With Major Depression
Sung Hee Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate
Lisa K. Stamp et al.
PHARMACOGENETICS AND GENOMICS (2010)
Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype
Halima Moncrieffe et al.
PHARMACOGENETICS AND GENOMICS (2010)
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis
Wouter M. Kooloos et al.
PHARMACOGENOMICS (2010)
Impact of OATP transporters on pharmacokinetics
A. Kalliokoski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
Lisa R. Trevin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism
Petra Bohanec Grabar et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis
Richard B. Warren et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+T cells
B. Baslund et al.
RHEUMATOLOGY (2008)
Reduced folate carrier-1 80G > A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis
M. Drozdzik et al.
PHARMACOGENOMICS JOURNAL (2007)
Transcription regulatory polymorphism-43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy
Anthoula Chatzikyriakidou et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines
Constanze Hilgendorf et al.
DRUG METABOLISM AND DISPOSITION (2007)
ABCB1 genotype and PGP expression, function and therapeutic drug response:: a critical review and recommendations for future research
G. D. Leschziner et al.
PHARMACOGENOMICS JOURNAL (2007)
Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine
Sofia Berggren et al.
MOLECULAR PHARMACEUTICS (2007)
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
Hilary A. Capell et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption
Andong Qiu et al.
CELL (2006)
The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs
Marek Drozdzik et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis
Thierry Dervieux et al.
ARTHRITIS AND RHEUMATISM (2006)
Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters
Stefan V. Vormfelde et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
SNPStats:: a web tool for the analysis of association studies
Xavier Sole et al.
BIOINFORMATICS (2006)
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis - Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
The human organic anion transporter 3 (OAT3; SLC22A8):: genetic variation and functional genomics
AR Erdman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Expression and function of efflux drug transporters in the intestine
M Takano et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis:: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
DX Wang et al.
PHARMACOGENETICS AND GENOMICS (2005)
Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6)
K Bleasby et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Epidemiology of adult rheumatoid arthritis
Y Alamanos et al.
AUTOIMMUNITY REVIEWS (2005)
How to predict prognosis in early rheumatoid arthritis
J Morel et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2005)
Toward a better understanding of methotrexate
JM Kremer
ARTHRITIS AND RHEUMATISM (2004)
Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules
S Ekaratanawong et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
The SLC22 drug transporter family
H Koepsell et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification
Nehal A. Kasim et al.
MOLECULAR PHARMACEUTICS (2004)
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis
T Dervieux et al.
ARTHRITIS AND RHEUMATISM (2004)
The multispecific organic anion transporter family: properties and pharmacological significance
H Miyazaki et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Pharmacogenetics in rheumatology: the prospects and limitations of an emerging field
C Siva et al.
RHEUMATOLOGY (2002)
Epidemiology and genetics of rheumatoid arthritis
Alan J. Silman et al.
ARTHRITIS RESEARCH & THERAPY (2002)
Molecular action of methotrexate in inflammatory diseases
ESL Chan et al.
ARTHRITIS RESEARCH (2002)
Polymorphisms in OATP-C -: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
RG Tirona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Genetic susceptibility to adverse drug reactions
M Pirmohamed et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset
EJA Kroot et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
The effect of rifampin treatment on intestinal expression of human MRP transporters
MF Fromm et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
J Konig et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
分享论文
